Therapeutic compounds and compositions
US8785450B2 · kind B2 · utility
31Cited by
34References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 2010 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Feb 24, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.